全文获取类型
收费全文 | 35395篇 |
免费 | 3659篇 |
国内免费 | 2533篇 |
专业分类
耳鼻咽喉 | 217篇 |
儿科学 | 479篇 |
妇产科学 | 392篇 |
基础医学 | 4306篇 |
口腔科学 | 651篇 |
临床医学 | 4630篇 |
内科学 | 5499篇 |
皮肤病学 | 319篇 |
神经病学 | 1597篇 |
特种医学 | 1148篇 |
外国民族医学 | 29篇 |
外科学 | 3817篇 |
综合类 | 6116篇 |
现状与发展 | 9篇 |
一般理论 | 3篇 |
预防医学 | 2432篇 |
眼科学 | 950篇 |
药学 | 3811篇 |
47篇 | |
中国医学 | 2108篇 |
肿瘤学 | 3027篇 |
出版年
2025年 | 22篇 |
2024年 | 634篇 |
2023年 | 887篇 |
2022年 | 1738篇 |
2021年 | 2149篇 |
2020年 | 1542篇 |
2019年 | 1273篇 |
2018年 | 1238篇 |
2017年 | 1160篇 |
2016年 | 1064篇 |
2015年 | 1565篇 |
2014年 | 1954篇 |
2013年 | 1754篇 |
2012年 | 2498篇 |
2011年 | 2797篇 |
2010年 | 1717篇 |
2009年 | 1363篇 |
2008年 | 1719篇 |
2007年 | 1850篇 |
2006年 | 1686篇 |
2005年 | 1613篇 |
2004年 | 1144篇 |
2003年 | 1103篇 |
2002年 | 960篇 |
2001年 | 783篇 |
2000年 | 762篇 |
1999年 | 765篇 |
1998年 | 451篇 |
1997年 | 469篇 |
1996年 | 355篇 |
1995年 | 345篇 |
1994年 | 328篇 |
1993年 | 184篇 |
1992年 | 227篇 |
1991年 | 231篇 |
1990年 | 238篇 |
1989年 | 184篇 |
1988年 | 155篇 |
1987年 | 121篇 |
1986年 | 123篇 |
1985年 | 93篇 |
1984年 | 70篇 |
1983年 | 39篇 |
1982年 | 27篇 |
1981年 | 22篇 |
1980年 | 14篇 |
1979年 | 20篇 |
1977年 | 16篇 |
1975年 | 14篇 |
1974年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Liposarcoma is a rare malignant tumor type and surgical resection is the gold standard treatment. The present study reported on the case of a 51-year-old woman who presented with a mass in the left upper abdomen. Computed tomography revealed a 32-cm giant retroperitoneal liposarcoma. Complete tumor resection was performed without the removal of other organs. Postoperative pathological examination indicated retroperitoneal well-differentiated liposarcoma and immunohistochemistry revealed S-100(−), MDM2(+), vimentin(+), CDK4(+), p16(+) and STAT6(+) results. The patient recovered well after the surgery. Complete tumor resection during the first surgery is key to cure liposarcoma. The present case report will be helpful for clinical oncologists to fully understand giant retroperitoneal liposarcoma and treat it accordingly. 相似文献
92.
Yao Lin Yiming Shao Yuchun Liu Ruoxuan Yang Shuanglin Liao Shuai Yang Mingwei Xu Junbing He 《Renal failure》2022,44(1):1263
BackgroundNafamostat mesilate (NM), a broad-spectrum and potent serine protease inhibitor, can be used as an anticoagulant during extracorporeal circulation, as well as a promising drug effective against coronavirus disease 2019 (COVID-19). We conducted a systematic meta-analysis to evaluate the safety and efficacy of NM administration in critically ill patients who underwent blood purification therapy (BPT).MethodsThe Cochrane Library, Web of Science and PubMed were comprehensively searched from inception to August 20, 2021, for potential studies.ResultsFour randomized controlled trials (RCTs) and seven observational studies with 2723 patients met the inclusion criteria. The meta-analysis demonstrated that conventional therapy (CT) significantly increased hospital mortality compared with NM administration (RR = 1.25, p = 0.0007). In subgroup analyses, the in-hospital mortality of the NM group was significantly lower than that of the anticoagulant-free (NA) group (RR = 1.31, p = 0.002). The CT interventions markedly elevated the risk ratio of bleeding complications by 45% (RR = 1.45, p = 0.010) compared with NM interventions. In another subgroup analysis, NM used exhibited a significantly lower risk of bleeding complications than those of the low-molecular-weight heparin (LMWH) used (RR = 4.58, p = 0.020). The filter lifespan was decreased significantly (MD = −10.59, p < 0.0001) in the NA groups compared with the NM groups. Due to the poor quality of the included RCTs, these results should be interpreted with caution.ConclusionGiven the better survival outcomes, lower risk of bleeding, NM anticoagulation seems to be a safe and efficient approach for BPT patients and could yield a favorable filter lifespan. More multi-center RCTs with large samples are required for further validation of this study. 相似文献
93.
目的 探讨项目管理在提高门诊肠镜患者肠道准备合格率中的应用效果.方法 成立项目管理团队,对门诊肠镜患者肠道准备合格率进行调查,找出影响合格率亟待改进的问题,实施项目管理,项目管理运用后再次进行调查,将调查结果与实施前进行比较.结果 项目管理实施后门诊肠镜患者肠道准备合格率显著高于实施前(P<0.01).结论 实施项目管... 相似文献
94.
95.
目的:采用不同孔径钛铝金属间化合物多孔材料(TAICPM)分离大黄虫丸,探讨经不同孔径TAICPM处理后的大黄虫丸抗动脉血栓形成的作用及机制。方法:选择70只SD雄性大鼠随机分为7组,其中正常组、模型组、对照组各10只,TAICPM组40只:1-5μm组、5-10μm组、10-15μm组、15-20μm组,每组各10只。血栓干重、血小板计数、血栓素B2(TXB-2)和6酮前列腺素F1α(6-keto-PGF1α)作为观察指标,评价经TAICPM分离后大黄虫丸抗动脉血栓形成的效果。结果:①对照组及TAICPM组血栓干重、血小板计数明显少于模型组(P<0.05),TXB-2和6-keto-PGF1α也较模型组有显著性差异(P<0.05);②TAICPM组血小板计数明显低于对照组(P<0.01),TXB-2和6-keto-PGF1α也较对照组有统计学差异(P<0.01);③1-5μm多孔材料组血栓干重明显低于其它3个多孔材料组(P<0.01),血小板计数、TXB-2和6-keto-PGF1α也较其它3组有显著性差异(P<0.01)。结论:经TAICPM处理后的大黄虫丸在抑制动脉血栓形成方面优于未处理的大黄虫丸,其中孔径为1-5μm的多孔材料效果更优。 相似文献
96.
目的: 探讨解聚复肾宁治疗早期糖尿病肾病(DN)的临床疗效。 方法: 研究对象为我院收治的120例早期2型DN患者,将其随机分为解聚复肾宁组、厄贝沙坦组、解聚复肾宁+厄贝沙坦组、对照组。每组各30例,12周为1疗程,观察各组治疗前后相关指标的变化。 结果: 解聚复肾宁组治疗后空腹血糖、24 h尿微量白蛋白排泄率、血肌酐、糖化血红蛋白等指标显著好转,血清和尿液中血管紧张素Ⅱ(AngⅡ),结缔组织生长因子(CTGF)均显著降低,解聚复肾宁和厄贝沙坦联合治疗明显优于两类药物单独应用(P<0.05)。 结论: 解聚复肾宁对早期2型DN疗效确切,可延缓病情进展,提高患者的生活质量,值得临床推广使用。 相似文献
97.
Hui-Jin Chen Ke-Lun Wei Cong-Le Zhou Yu-Jia Yao Yu-Jia Yang Xiu-Fang Fan Xi-Rong Gao Xiao-Hong Liu Ji-Hong Qian Ben-Qing Wu Gao-Qiang Wu Qing-Mei Zhang Xiao-Lan Zhang 《World journal of pediatrics : WJP》2013,9(1):17-24
Background
There is a large number (1.5 million per year) of premature births in China. It is necessary to obtain the authentic incidences of intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL), the common brain injuries, in Chinese premature infants. The present multicenter study aimed to investigate the incidence of brain injuries in premature infants in ten urban hospitals in China.Methods
The research proposal was designed by the Subspecialty Group of Neonatology of Pediatric Society of the Chinese Medical Association. Ten large-scale urban hospitals voluntarily joined the multicenter investigation. All premature infants with a gestational age ≤34 weeks in the ten hospitals were subjected to routine cranial ultrasound within three days after birth, and then to repeated ultrasound every 3–7 days till their discharge from the hospital from January 2005 to August 2006. A uniform data collection sheet was designed to record cases of brain injuries.Results
The incidences of overall IVH and severe IVH were 19.7% (305/1551) and 4.6% (72/1551), respectively with 18.4% (56/305) for grade 1, 58.0% (177/305) for grade 2, 17.7% (54/305) for grade 3 and 5.9% (18/305) for grade 4 in nine hospitals. The incidences of overall PVL and cystic PVL were 5.0% (89/1792) and 0.8% (14/1792) respectively, with 84.3% (75/89) for grade 1, 13.5% (12/89) for grade 2, and 2.2% (2/89) for grade 3 in the ten hospitals. The statistically significant risk factors that might aggravate the severity of IVH were vaginal delivery (OR=1.883, 95% CI: 1.099–3.228, P=0.020) and mechanical ventilation (OR=4.150, 95% CI: 2.384–7.223, P=0.000). The risk factors that might result in the development of cystic PVL was vaginal delivery (OR=21.094, 95% CI: 2.650–167.895, P=0.000).Conclusions
The investigative report can basically reflect the incidence of brain injuries in premature infants in major big cities of China. Since more than 60% of the Chinese population live in the rural areas of China, it is expected to undertake a further multicenter investigation covering the rural areas in the future. 相似文献98.
99.
100.